We are live on
!
Find out more
OQS
Occudo Quantitative Strategies Portfolio holdings
AUM
$1.84B
1-Year Est. Return
22.15%
This Fund
S&P 500
This Quarter
Est. Return
+31.86%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$319M
AUM Growth
–
Cap. Flow
+$291M
Cap. Flow
% of AUM
91.41%
Top 10 Holdings %
Top 10 Hldgs %
6.07%
Holding
629
New
628
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$2.05M |
| 2 |
Jack Henry & Associates
JKHY
|
+$1.99M |
| 3 |
Akamai
AKAM
|
+$1.98M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$1.9M |
| 5 |
Qualcomm
QCOM
|
+$1.86M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.43% |
| 2 | Technology | 17.77% |
| 3 | Consumer Discretionary | 14.34% |
| 4 | Industrials | 13.38% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RETA
526
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $216K | 0.07% |
+1,750
| New | +$230K |
|
527
Vaxcyte
PCVX
$7.9B
| $215K | 0.07% |
+8,089
| New | +$301K |
|
528
Relmada Therapeutics
RLMD
$574M
| $215K | 0.07% |
+6,715
| New | +$231K |
|
529
Alpha and Omega Semiconductor
AOSL
$1.01B
| $214K | 0.07% |
+9,036
| New | +$184K |
|
530
Amgen
AMGN
$210B
| $213K | 0.07% |
+928
| New | +$214K |
|
531
Domo
DOMO
$181M
| $213K | 0.07% |
+3,346
| New | +$144K |
|
532
Evercore
EVR
$12.4B
| $213K | 0.07% |
+1,939
| New | +$173K |
|
533
Green Brick Partners
GRBK
$3.1B
| $212K | 0.07% |
+9,214
| New | +$192K |
|
534
Zillow
ZG
$8.47B
| $212K | 0.07% |
+1,561
| New | +$176K |
|
535
Albany International
AIN
$1.79B
| $211K | 0.07% |
+2,875
| New | +$181K |
|
536
Genuine Parts
GPC
$18.3B
| $211K | 0.07% |
+2,101
| New | +$206K |
|
|
SI
537
DELISTED
Silvergate Capital Corporation
SI
| $211K | 0.07% |
+2,833
| New | +$93.4K |
|
538
Huntington Bancshares
HBAN
$35.5B
| $210K | 0.07% |
+16,642
| New | +$189K |
|
|
RDUS
539
DELISTED
Radius Health, Inc.
RDUS
| $210K | 0.07% |
+11,745
| New | +$176K |
|
540
Fastenal
FAST
$57B
| $209K | 0.07% |
+8,578
| New | +$202K |
|
541
Materion
MTRN
$4.72B
| $209K | 0.07% |
+3,280
| New | +$189K |
|
542
O-I Glass
OI
$1.16B
| $208K | 0.07% |
+17,490
| New | +$200K |
|
543
Dropbox
DBX
$8.05B
| $207K | 0.07% |
+9,321
| New | +$190K |
|
544
United Therapeutics
UTHR
$22B
| $207K | 0.07% |
+1,364
| New | +$179K |
|
545
Nu Skin
NUS
$259M
| $205K | 0.06% |
+3,749
| New | +$197K |
|
546
Ulta Beauty
ULTA
$23.4B
| $205K | 0.06% |
+715
| New | +$181K |
|
547
Chefs' Warehouse
CHEF
$4.49B
| $204K | 0.06% |
+7,956
| New | +$156K |
|
548
Century Casinos
CNTY
$34.3M
| $204K | 0.06% |
+31,922
| New | +$184K |
|
549
Community Health Systems
CYH
$417M
| $204K | 0.06% |
+27,460
| New | +$194K |
|
550
Northwest Bancshares
NWBI
$2.34B
| $203K | 0.06% |
+15,933
| New | +$182K |
|
Similar funds
RP
ABTD
KAM
FCIM
CPSAC
OFS
LOAME
DP
Occudo Quantitative Strategies's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Occudo Quantitative Strategies, which disclosed 629 positions worth $319M. Its ten largest holdings account for 6.1% of the portfolio.
Its largest position is Danaher: 10,223 shares worth $2.01M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, followed by Technology and Consumer Discretionary.
- Occudo Quantitative Strategies's largest Q4 2020 buy was Danaher: 10,223 shares worth $2.01M.
- Occudo Quantitative Strategies's ten largest holdings make up 6.1% of its $319M portfolio in Q4 2020.
- Occudo Quantitative Strategies disclosed 629 positions in Q4 2020, its first 13F filing on record.
Based on Occudo Quantitative Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.